{
    "2020-01-02": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Global Blood (GBT) Shares Double in a Year, Focus on Oxbryta",
                "features": {
                    "keywords": [
                        "Global Blood",
                        "Shares Double",
                        "Oxbryta"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Balanced Risk",
                        "Reward"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}